EGFR and intracranial hypertension: In conclusion, our data demonstrate that CSF shunting may effectively control intracranial hypertension due to LM-H from lung adenocarcinoma in patients with an EGFR mutation, especially for patients with a good ECOG PS and controlled extracranial cancer.